Loading Events

« All Events

  • This event has passed.

Marcum New England Life Science & Biotech Summit

September 21 @ 1:00 pm - 6:30 pm

The Marcum New England Life Science & Biotech Summit presented in collaboration with CBIA is dedicated to updating innovative early emerging growth and later stage life science and biotech companies, stakeholders, and trusted advisors of the industry.

Stay up to date on innovative early emerging growth and later stage life science and biotech companies, stakeholders, and trusted advisors of the industry.

1 pm | Check-In & Networking

1:55 pm | Opening Remarks

  • Chris DiPentima, President & CEO, CBIA
  • Michael Brooder, National Technology & Life Sciences Leader, Marcum LLP

2 pm | The BioTech Innovation Landscape

  • Angela Hwang, Pfizer’s chief commercial officer and president of its global biopharmaceuticals business talks with Connecticut Bioscience Growth Council executive director Paul Pescatello.

2:45 | Transforming Biotech in Connecticut

  • Moderator: Dan Wagner, Senior Managing Director, Investments, Connecticut Innovations
  • State Senator Christine Cohen (D-Guilford)
  • Josh Geballe, Senior Associate Provost for Entrepreneurship & Innovation, Yale University
  • State Senator Tony Hwang (R-Fairfield)

3:30 pm | Healthcare Innovations

  • Tim Archer, CEO, New England Health Plan, United Healthcare
  • Brian Cuddeback, VP, Sales & Client Management, Cigna Healthcare
  • Lee Schwamm, Chief Digital Health Officer & Associate Dean of Digital Strategy & Innovation, Yale School of Medicine; SVP, Yale New Haven Health System
  • Barry Stein, Chief Clinical Innovation Officer & Chief Medical Informatics Officer, Hartford HealthCare

4:15 pm | Capital Markets & the Economy

  • David Allebach, Managing Director, Corporate Advisory Group Head, Janney Montgomery Scott
  • Mark Luschini, Chief Investment Strategist, Janney Montgomery Scott; President & Chief Investment Officer, Janney Capital Management
  • David Reed, Managing Director, Investment Banking, Janney Montgomery Scott

4:45 pm | Networking Reception

Details

Date:
September 21
Time:
1:00 pm - 6:30 pm
Website:
https://www.marcumevents.com/events/marcum-new-england-life-science-biotech-summit-2023

The Marcum New England Life Science & Biotech Summit presented in collaboration with CBIA is dedicated to updating innovative early emerging growth and later stage life science and biotech companies, stakeholders, and trusted advisors of the industry.

Stay up to date on innovative early emerging growth and later stage life science and biotech companies, stakeholders, and trusted advisors of the industry.

1 pm | Check-In & Networking

1:55 pm | Opening Remarks

  • Chris DiPentima, President & CEO, CBIA
  • Michael Brooder, National Technology & Life Sciences Leader, Marcum LLP

2 pm | The BioTech Innovation Landscape

  • Angela Hwang, Pfizer’s chief commercial officer and president of its global biopharmaceuticals business talks with Connecticut Bioscience Growth Council executive director Paul Pescatello.

2:45 | Transforming Biotech in Connecticut

  • Moderator: Dan Wagner, Senior Managing Director, Investments, Connecticut Innovations
  • State Senator Christine Cohen (D-Guilford)
  • Josh Geballe, Senior Associate Provost for Entrepreneurship & Innovation, Yale University
  • State Senator Tony Hwang (R-Fairfield)

3:30 pm | Healthcare Innovations

  • Tim Archer, CEO, New England Health Plan, United Healthcare
  • Brian Cuddeback, VP, Sales & Client Management, Cigna Healthcare
  • Lee Schwamm, Chief Digital Health Officer & Associate Dean of Digital Strategy & Innovation, Yale School of Medicine; SVP, Yale New Haven Health System
  • Barry Stein, Chief Clinical Innovation Officer & Chief Medical Informatics Officer, Hartford HealthCare

4:15 pm | Capital Markets & the Economy

  • David Allebach, Managing Director, Corporate Advisory Group Head, Janney Montgomery Scott
  • Mark Luschini, Chief Investment Strategist, Janney Montgomery Scott; President & Chief Investment Officer, Janney Capital Management
  • David Reed, Managing Director, Investment Banking, Janney Montgomery Scott

4:45 pm | Networking Reception